Literature DB >> 31331622

Transitions of Care for Patients with Neurologic Diagnoses Transition from the Intensive Care Unit to the Floor.

Molly McNett1, Diane McLaughlin2.   

Abstract

Transition of care from the intensive care unit to acute care units after critical neurologic injury includes the consideration of a variety of factors to ensure safe and effective care, and promote ongoing neurologic recovery. Assessment of effectiveness of deescalation techniques, agitation management, and risk factor mitigation are important strategies to enhance the success of transitions. Clear and consistent interdisciplinary communication between teams during hand-off between units is imperative to decrease the risk of complications and errors, and to streamline discharge processes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neurocritical care; Neurology; Neurosurgery; Patient transfer; Transition of care

Mesh:

Year:  2019        PMID: 31331622     DOI: 10.1016/j.cnur.2019.04.005

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  3 in total

1.  Factors Influencing the Decision-making of Healthcare Providers Regarding the Transition of Patients from the Intensive Care Unit to the General Ward in Iran: A Qualitative Study.

Authors:  Kobra Ghorbanzadeh; Abbas Ebadi; Mohammadali Hosseini; Sadat Seyed Bagher Maddah; Hamidreza Khankeh; Maryam Khoshbakht Pishkhani; Vahid Adiban
Journal:  Indian J Crit Care Med       Date:  2022-05

Review 2.  A Review of Neuronal Pathways Associated With Consciousness.

Authors:  Malissa Mulkey; D Erik Everhart; Amy Gencarelli; Anne Sorrell; Sungham Kim
Journal:  J Neurosci Nurs       Date:  2021-02-01       Impact factor: 1.230

3.  Effects of MBSR therapy on negative emotions, fatigue, and sleep quality in "post-ICU patients": A randomized controlled clinical trial protocol.

Authors:  Yu Chen; Renying Wang; Jie Yu; Liping Zhu; Yiming Lu; Xueqin Deng
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.